WALTHAM, Mass., Oct 28, 2010 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) will host a conference call at 4:30 p.m. ET on Thursday, November 4, 2010, to discuss the company's financial results for the second quarter of fiscal 2011. Management will review the quarter and provide an update on the company.
The conference call will be webcast on the investor relations section of Alkermes' website at http://www.alkermes.com or may be accessed by dialing 1-888-517-2470for domestic callers and 1-630- 827-6818for international callers. The conference call ID number is 7262488.
A replay of the conference call will be available from 7:30 p.m. ET on Thursday, November 4, 2010, through 5:00 p.m. ET on Thursday, November 11, 2010, and may be accessed by visiting Alkermes' website or by dialing 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The replay access code is 7262488.
About Alkermes
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.
SOURCE: Alkermes
Alkermes, Inc.
Eva Stroynowski, 781-609-6823
Corporate Communications